Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Baylor University Medical Center located at 3500 Gaston Ave, Dallas, TX, 75246 & includes data from NPIs 1184029811, 1447250253
Dexur analyzed Q1 2017 (January to March 2017) Medicare claims data to benchmark length of stay (LOS) outcomes for Baylor University Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 3,395 | 3,182 | ||||||||||
| Surgical | 1,163 | 1,119 | ||||||||||
| Non Surgical | 2,232 | 2,063 | ||||||||||
| General Medicine | 517 | 465 | ||||||||||
| Cardiovascular | 450 | 420 | ||||||||||
| General Surgery | 412 | 381 | ||||||||||
| Orthopedics | 387 | 381 | ||||||||||
| Gastroenterology & Endocrinology | 344 | 332 | ||||||||||
| Pulmonology | 329 | 299 | ||||||||||
| Neurology | 297 | 264 | ||||||||||
| Urology | 271 | 266 | ||||||||||
| Oncology & Hematology | 142 | 135 | ||||||||||
| Colorectal | 80 | 79 | ||||||||||
| Spine | 78 | 75 | ||||||||||
| Obstetrics & Gynecology | 29 | 29 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 28 | 26 | ||||||||||
| Psychiatry & Mental Disorders | 20 | 20 | ||||||||||
| Dermatology | 11 | NA |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 433: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Otitis Media And Upper Respiratory Infection | ||||||||||||
| DRG 153: OTITIS MEDIA AND URI WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hiv With Major Related Condition |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hypertension | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| Heart Transplant Or Implant Of Heart Assist System | ||||||||||||
| DRG 001: HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
| DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||
| Non-Extensive Procedure Unrelated To Principal Diagnosis |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| Fractures Of Hip And Pelvis | ||||||||||||
| DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Biliary Tract | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Cholecystectomy | ||||||||||||
| Liver Or Intestinal Transplant | ||||||||||||
| DRG 005: LIVER TRANSPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR INTESTINAL TRANSPLANT |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| DRG 086: TRAUMATIC STUPOR AND COMA, COMA <1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma > 1 Hour |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Other Kidney And Urinary Tract Procedures | ||||||||||||
| Transurethral Procedures |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chemotherapy | ||||||||||||
| DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Nervous System Neoplasms | ||||||||||||
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cervical Spinal Fusion | ||||||||||||
| Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2017 to Mar 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |